Regional Media

mainly cloudy 73°. Wind: S 4 mph.
Loading advertisement…
Trending: US Supreme Court poised to rule on gun laws and transgender athletes
HomeNewsNationalHealth ( Page 107)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Ex-COPA deputy who revealed boss’ anti-cop bias can’t sue over firing

A federal judge has tossed a lawsuit from a former top investigator for the Chicago city office responsible for investigating police misconduct claims, who had claimed he was illegally fired in retaliation for casting light on politically motivated and slanted anti-police investigations under the ...
by

Lawsuit demands Pritzker’s office release docs over pic with criminal

Illinois Gov. JB Pritzker's office has illegally attempted to scrub from the public record photos and other proof that he posed at an event in Chicago with a man, paid by the state as a so-called "peacekeeper," who would be arrested two weeks burglary ...
by

Illinois Quick Hits: FEMA says no to Illinois disaster declaration

(The Center Square) - The Federal Emergency Management Agency has denied the state of Illinois' appeal for a major disaster declaration following severe storms and flooding that affected Boone, Cook, Kane, McHenry and Will counties in August. ...
by

Lawmaker: Conversion therapy funding ban ‘hypocritical’ amid youth gender care doubts

(The Center Square) - Illinois lawmakers are advancing legislation to prohibit taxpayer funding for conversion therapy, even as the state continues to spend public dollars on gender-affirming care resources - a contradiction critics say exposes a deeper ideological divide over government-funded counseling and healthcare. ...
by

Incyte weak 2026 revenue forecast heightens Jakafi patent concerns

Feb 10 (Reuters) - Incyte forecast annual sales below Wall Street estimates on Tuesday with its key growth driver Opzelura expected to underperform, raising concerns about the drugmaker's ability to offset looming patent losses on top-seller Jakafi. Shares of the Wilmington, Delaware-based company fell over ...
by

Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand

Feb 10 (Reuters) - Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street estimates after beating expectations for fourth-quarter results on strong demand for its diagnostic tests. The laboratory operator expects its 2026 adjusted profit to be in the range of $10.50 ...
Loading advertisement…
by

Israeli drone strike kills 2 cyclists in Gaza as death toll mounts despite ceasefire

DEIR AL-BALAH, Gaza Strip (AP) - Two Palestinians on bicycles were killed in an Israeli drone strike on Tuesday, hospital officials said, marking the latest deaths since an October ceasefire that hasn't halted deadly attacks in the Gaza Strip. Al-Aqsa Martyrs Hospital said the two ...
by

Zimmer Biomet beats quarterly estimates on strong hips, knees device demand

Feb 10 (Reuters) - Zimmer Biomet on Tuesday beat Wall Street estimates for fourth-quarter profit and revenue as the company capitalized on steady demand for its devices used in orthopedic procedures. Shares of the Warsaw, Indiana based company rose 1.5% in premarket trading. The orthopedic ...
by

Australia’s CSL turns to ex-vaccine division head after CEO McKenzie retires

By Rajasik Mukherjee Feb 10 (Reuters) - Australia's CSL tapped insider Gordon Naylor as interim CEO on Tuesday after announcing the retirement of current chief Paul McKenzie, as the biotech firm seeks to soothe shareholder worries over falling U.S. vaccination rates and profit growth. The changes ...
by

India’s Lupin settles US patent dispute with Astellas Pharma for $90 million

Feb 10 (Reuters) - Indian drugmaker Lupin said on Tuesday it agreed to a $90 million settlement with Japan's Astellas Pharma in a patent dispute over the bladder disorder drug Mirabegron, a move that allows it to continue selling the product in the United ...
by

AstraZeneca forecasts growth in 2026 as it builds drug pipeline

(Corrects to fix typo in paragraph 7) Feb 10 (Reuters) - AstraZeneca on Tuesday forecast profit and sales growth in 2026, betting on demand for its cancer treatments and newer drugs as it pushes expansion in the United States and China. The outlook comes as longtime ...
by

China biotech aims to finish trials by 2028 for spray with Wegovy active ingredient

SHANGHAI, Feb 10 (Reuters) - Shanghai Shiling Pharmaceutical is aiming to complete global clinical trials by 2028 for an experimental weight-management spray that uses the same active ingredient as Novo Nordisk's Wegovy obesity injection, the Chinese biotech said on Tuesday. Danish drugmaker Novo, Eli Lilly ...
First Previous103104105106107108109Next Last